The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s

NCT04011527 · tracked via the Priya Life Science Germany tracker

Sponsor

Segeberger Kliniken GmbH

Phase

Observational

Started

2002-11-25

Last updated

2022-06-06

Condition(s) studied

Coronary Artery Disease

Investigational drug(s) / intervention(s)

Rotational Atherectomy in Coronary Lesion/s

Study summary

A Prospective Follow-up Assessment in Bad Segeberg with Patients undergoing a Rotational Atherectomy in Coronary Lesion/s

Eligibility

Sex

ALL

Min age

18 Years

Max age

100 Years

Healthy volunteers

Inclusion Criteria: * All patients undergoing a rotational atherectomy of coronary lesion/s Exclusion Criteria: * None

Primary outcome measure(s)

Rate of in-hospital and long-term cardiovascular adverse events in percent — 2 years
Peri-procedural events and in-hospital cardiovascular events and long-term cardiovascular events (bleeding, peripheral and coronary vascular complication, stroke, myocardial infarction, stent thrombosis, revascularization, death)

Trial sites (1)

Facility	City	Region	Status
Herzzentrum Segeberger Kliniken GmbH	Bad Segeberg	Germany	Recruiting

More Segeberger Kliniken GmbH trials in Germany

The Prospective Segeberg TAVI Registry Recruiting

The Prospective Segeberg Registry for Coronary Chronic Total Occlusions (CTO) Recruiting

The Prospective Segeberg Registry for Mitral Transcatheter Edge-to-Edge Repair Recruiting

Other trials for the same condition

Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial Active, not recruiting

The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial Active, not recruiting

Correlation of FFR and iFR With Cardiac PET Perfusion in Patients With Severe Aortic Valve Stenosis Recruiting

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions Recruiting

SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF) Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04011527 on ClinicalTrials.gov ↗ ← All trials in Germany